Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Omnicell is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13G/A2026-08-10SCHEDULE 13G/A
- 10-Q2026-08-05Quarterly report
- 8-K2026-07-30Current report (material event)
- S-82026-07-07Employee stock plan
- 8-K2026-07-01Current report (material event)
- SD2026-05-29SD
- 8-K2026-05-26Current report (material event)
- SCHEDULE 13G2026-05-15SCHEDULE 13G
- 10-Q2026-05-06Quarterly report
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- 8-K2026-04-28Current report (material event)
- ARS2026-04-13Annual report to holders
- DEF 14A2026-04-13Proxy statement
- PRE 14A2026-04-02PRE 14A
- SCHEDULE 13G2026-04-01SCHEDULE 13G
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 10-K2026-02-26Annual report
- 8-K2026-02-05Current report (material event)
- 8-K2025-12-08Current report (material event)
- 10-Q2025-11-05Quarterly report
- 8-K2025-10-30Current report (material event)
- SCHEDULE 13G2025-10-09SCHEDULE 13G
- 8-K2025-10-06Current report (material event)
- 8-K2025-08-25Current report (material event)
- 10-Q2025-08-06Quarterly report
- 8-K2025-07-31Current report (material event)
- S-82025-06-18Employee stock plan
- 8-K2025-06-05Current report (material event)
- 8-K2025-05-23Current report (material event)
- SD2025-05-22SD
- 8-K2025-05-22Current report (material event)
- 10-Q2025-05-07Quarterly report
- 8-K2025-05-06Current report (material event)
- SCHEDULE 13G/A2025-04-28SCHEDULE 13G/A
- ARS2025-04-03Annual report to holders
- DEF 14A2025-04-03Proxy statement
- 8-K2025-03-12Current report (material event)
- 8-K2025-03-04Current report (material event)
- 10-K2025-02-27Annual report
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.